TABLE 1 MAJOR REGULATORY AUTHORITY WORLD WIDE
TABLE 2 CLINICAL TRAILS ONGOING ON DIFFERENT LIVER DISEASES
TABLE 3 WORLD ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 4 NORTH AMERICA ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 5 EUROPE ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 6 ASIA PACIFIC ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 7 LAMEA ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 8 WORLD VACCINES MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 9 NORTH AMERICA VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 10 EUROPE VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 11 ASIA PACIFIC VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 12 LAMEA VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 13 WORLD ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 14 NORTH AMERICA ANTI REJECTION DRUGS / IMMUNOSUPPRESANT
TABLE 15 EUROPE ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 16 ASIA PACIFIC ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 17 LAMEA ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 18 WORLD CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 19 NORTH AMERICA CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 20 EUROPE CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 21 ASIA PACIFIC CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 22 LAMEA CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 23 WORLD TARGETED THERAPY MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 24 NORTH AMERICA TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 25 EUROPE TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 26 ASIA PACIFIC TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 27 LAMEA TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 28 WORLD IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 29 NORTH AMERICA IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 30 EUROPE IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 31 ASIA PACIFIC IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 32 LAMEA IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 33 WORLD CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 34 NORTH AMERICA CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 35 EUROPE CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 36 ASIA PACIFIC CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 37 LAMEA CORTOCOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 38 NORTH AMERICA MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 39 U.S. LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 40 MEXICO LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 41 CANADA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 42 WORLD EUROPE MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 43 GERMANY LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 44 UK LIVER DISEASE TREATMENT, ($MILLION), GROWTH (%) 2014-2022
TABLE 45 ITALY LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 46 FRANCE LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 47 REST OF EUROPE LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 48 ASIA PACIFIC MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 49 JAPAN LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 50 CHINA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 51 INDIA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 52 REST OF APAC LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 53 LAMEA MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 54 LATIN AMERICA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 55 MIDDLE EAST LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 56 AFRICA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022

LIST OF FIGURE

FIG. 1 TOP IMPACTING FACTORS
FIG. 2 TOP WINNING STRATEGIES IN THE LIVER DISEASE TREATMENT MARKET (20132016)
FIG. 3 TOP WINNING STRATEGIES (%) (20132016)
FIG. 4 TOP INVESTMENT POCKETS
FIG. 5 PORTERS FIVE FORCES ANALYSIS OF LIVER DISEASE TREATMENT MARKET
FIG. 6 MARKET SHARE ANALYSIS OF LIVER DISEASE TREATMENT MARKET, BY ANTIVIRAL DRUGS MARKET, 2015
FIG. 7 MARKET SHARE ANALYSIS OF LIVER DISEASE TREATMENT MARKET, BY ANTIREJECTION DRUGS / IMMUNOSUPPRESSANT DRUGS MARKET, 2015
FIG. 8 WORLD AGEING POPULATION EXPECTED GROWTH RATE, 2000, 2025 AND 2050
FIG. 9 DEVELOPMENT AND REGULATORY TIME PROFILE FOR NEW DRUG
FIG. 10 CLINICAL PHASE TRASITION PROBABILITY AND OVERALL CLINICAL APPROVAL SUCCESS RATE
FIG. 11 WORLD LIVER DISEASE TREATMENT MARKET BY TREATMENT TYPE, 2015 (PIE CHART OF GLOBAL NUMBERS BY TREATMENT TYPE)
FIG. 12 WORLD ANTIVIRAL DRUGS MARKET, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 13 WORLD VACCINES MARKET, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 14 WORLD ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 15 WORLD LIVER DISEASE TREATMENT MARKET, BY CHEMOTHERAPY DRUGS, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 16 WORLD TARGETED THERAPY MARKET, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 17 WORLD IMMUNOGLOBULIN MARKET , YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 18 WORLD LIVER DISEASE TREATMENT MARKET, BY CORTICOSTEROIDS , YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 19 WORLD LIVER DISEASE TREATMENT MARKET BY GEOGRAPHY, 2015(PIE CHART OF GLOBAL NUMBERS BY GEOGRAPHY)
FIG. 20 WORLD NORTH AMERICA MARKET, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 21 WORLD EUROPE MARKET, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 22 WORLD LIVER DISEASE TREATMENT MARKET, BY ASIA PACIFIC, YEAR ON YEAR GROWTH(%), 2015-2022
FIG. 23 WORLD LAMEA MARKET, YEAR ON YEAR GROWTH(%), 2015-2022